Commerce Bank’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,631
Closed -$343K 1177
2023
Q1
$343K Buy
14,631
+888
+6% +$25.4K ﹤0.01% 939
2022
Q4
$374K Buy
13,743
+6,357
+86% +$291K ﹤0.01% 895
2022
Q3
$398K Buy
7,386
+95
+1% +$4.88K ﹤0.01% 853
2022
Q2
$294K Buy
+7,291
New +$361K ﹤0.01% 953
2022
Q1
Sell
-3,175
Closed -$318K 1197
2021
Q4
$318K Sell
3,175
-35,154
-92% -$3.64M ﹤0.01% 1006
2021
Q3
$4.79M Buy
38,329
+1,876
+5% +$223K 0.03% 325
2021
Q2
$4.53M Buy
36,453
+4,453
+14% +$599K 0.03% 346
2021
Q1
$4.89M Sell
32,000
-5,312
-14% -$803K 0.04% 315
2020
Q4
$4.81M Sell
37,312
-1,265
-3% -$146K 0.04% 315
2020
Q3
$4.31M Sell
38,577
-7,167
-16% -$656K 0.04% 299
2020
Q2
$3.71M Buy
+45,744
New +$3.69M 0.04% 318

Other funds holding GH

Commerce Bank's GH Position: Q2 2023 in Review

Commerce Bank sold out of Guardant Health (GH) in Q2 2023, closing a stake of 14,631 shares — an estimated $343K sold.

Commerce Bank first reported a position in GH in Q2 2020 and held it in 11 quarters. The position peaked at $4.89M in Q1 2021. 299 funds tracked by Wall St. Rank hold GH as of Q2 2023.

  • Commerce Bank reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
  • Commerce Bank sold 14,631 Guardant Health shares in Q2 2023, an estimated $343K.
  • Commerce Bank first reported a position in Guardant Health in Q2 2020 and held it in 11 quarters.
  • Commerce Bank's Guardant Health position peaked at $4.89M in Q1 2021.
  • 299 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Commerce Bank's 13F filing for Q2 2023, filed 8 Aug 2023.